More importantly, selective removal of APOE ε4 from astrocytes significantly reduces tau-mediated neurodegeneration, a finding that emphasizes the central role of astrocyte-derived APOE ε4 in AD pathological progression [18]. Here, MAPT is linked to Alzheimer disease.